Having reviewed documents for sponsors, CROs, and investigator sites for eight years, I’ve noticed something constant. The people who deal with the data often know about the issues. They just fail to correct them on time.

Imagine this. Your site keeps enrolling patients using an old version of the consent form for several weeks after a revised version has been approved. Another site signs off on a training record while not being well-versed in the actual protocol. A third site leaves a deviation out of the monthly log because it does not seem critical enough, while a fourth site reports an identical deviation the very same day it occurs. Taken separately, each may look like an isolated issue. But taken together, they reveal a system of quality assurance that works on paper. And auditors and inspectors know how to spot it.

When evaluating GCP consultancy services in India, this distinction matters. Either you identify the problems beforehand and write your own corrective actions at your own pace or you’ll have to perform the same work but within a time limit you didn’t choose. Sponsors researching GCP services in India or GCP services in Ahmedabad run into this same decision point, and the gaps below apply whether the study is run locally or across multiple countries. This overlap is also where GCP in pharmacovigilance becomes relevant, since safety data collected during a trial has to hold up to the same documentation standards as the clinical record itself.

“Inspection readiness cannot be achieved in the couple of weeks before an inspection. It is determined by the way your study runs on an ordinary Tuesday.”

Here are the seven most common GCP readiness problems.

1. You fail to track ICF version control

You approve a revised informed consent form. Your site keeps using the old version for several weeks before anyone catches the problem. Similarly, tracking re-consents can be equally difficult and fall into the same communication gap between sponsors and sites. Auditors are interested in the form itself, but also in what it reveals – poor document tracking and distribution processes. This is one of the first things a GCP audit services India engagement should flag, since consent tracking sits at the center of most GCP regulatory requirements.

2. The TMF accumulates too much documentation debt

Your delegation log misses a signature. Correspondence gets filed several weeks late. A visit report is not added to your file. All of these gaps look harmless separately. But several of them, accumulated over time, turn the TMF into a messy narrative of what happened in the course of your study. Solve this problem with periodic completeness checks according to a fixed schedule. Don’t wait till you scramble before the arrival of the inspector.

3. Your training documentation confirms only attendance

The signature in your training record shows that the person attended the training session. But it does not confirm that this person understands the protocol and received it in advance. This gap gets wider with staff turnover and protocol amendments, when tasks are delegated and documentation is backfilled later. And the right question you should ask yourself: did this person receive training on the protocol beforehand, or did he or she have to rush to catch up?

4. Different sites treat deviations differently

One of your sites reports every small deviation as part of the routine. The other uses a higher reporting threshold and reports only what it considers significant deviations. As a result, you lose the signal you really need: is this a random error or the regular pattern? Define the rules clearly and centralize your review process at the sponsor level. In such a way, you will close this gap fast.

Case in point. Looking at each site’s training file separately, nothing appeared problematic. Comparing them across sites revealed a completely different picture. Some of your staff members got involved in protocol-specific tasks before anyone documented their training. Missing dates were not the actual issue. What really mattered was that every site was self-certifying its own readiness when it should have been controlled centrally by the sponsor.

A gap in one site is a site-related problem. A gap in three sites is a sponsor problem. Not sure how audit-ready your sites really are?

An independent GCP readiness review can uncover cross-site gaps before they become inspection findings. Talk to Pharmazone about your GCP inspection readiness. 

5. The process of vendor oversight is just on paper

Delegating some processes to a CRO or laboratory does not transfer the sponsor’s ultimate responsibility. You still need documented evidence that you have been reviewing the vendor’s performance and closing out the CAPAs. An agreement signed and filed in a folder doesn’t serve as evidence. The problem becomes even more complicated as you manage more and more sites and vendors simultaneously. This is exactly where structured GCP compliance consulting earns its place, since an outside reviewer can catch oversight gaps a sponsor’s own team has grown used to overlooking.

6. RBQM framework stays in your SOPs but is not applied

Sponsors may have created an RBQM framework for themselves. But not all apply it in practice. If the monitoring intensity for every site is the same regardless of the risk level, the framework remains just an ornament. This can draw scrutiny because monitoring intensity should be informed by the risk assessment.

7. Data integrity controls are not updated after the study changes

You add new users. You change the roles. You integrate platforms in the middle of the study. Audit trails and access permissions that worked properly at the beginning of the study may not get updated. And your exposure increases gradually, making it difficult to notice until it is too late.

Inspection readiness is an operating discipline, not just a hunt for documents

An inspection readiness review that stops at “here is what’s missing” does not understand the true point. Training, vendor oversight, monitoring, and data integrity should function as one cohesive system, not four individual checklists. If the findings are to carry real regulatory value, it is better to involve an experienced regulatory affairs team beforehand. Otherwise, you’ll end up with reactive correction. Sponsors comparing GCP auditing services or looking specifically for GCP Auditing Services in India should treat this systems-level view as the real benchmark, not just a checklist of missing documents.

Identify the gaps before the others do

Are you preparing for an audit or inspection? Would you like an independent assessment of your situation? Get in touch with Pharmazone about your GCP inspection readiness needs.